Klippel-Trenaunay Syndrome
Also known as: KTS, Angio-osteohypertrophy syndrome, Klippel-Trenaunay-Weber Syndrome
Klippel-Trenaunay Syndrome (KTS) is a rare congenital vascular disorder characterized by the triad of port-wine stain (capillary malformation), varicose veins, and bony and soft tissue hypertrophy, typically affecting one or more limbs. The severity of symptoms varies widely among affected individuals. While the exact cause is unknown, it is thought to be due to sporadic genetic mutations occurring during embryonic development.
Imagine some of your blood vessels and bones grew a little differently before you were born. This can cause a birthmark (like a wine stain), some bigger veins, and maybe one of your arms or legs is a bit bigger than the other. Doctors can help manage these things to make you feel better.
Signs & Symptoms
- Port-wine stain (capillary malformation)
- Varicose veins
- Limb hypertrophy (overgrowth)
- Venous malformations
- Lymphatic malformations
- Arteriovenous malformations (rare)
- Pain
- Swelling
- Bleeding
- Cellulitis
- Deep vein thrombosis (DVT)
- Pulmonary embolism (PE)
- Discrepancy in limb length
- Macrodactyly (enlarged digits)
Treatment Options
Compression therapy
MODERATELY EFFECTIVESclerotherapy
MODERATELY EFFECTIVELaser therapy
MODERATELY EFFECTIVESurgery (e.g., vein stripping, epiphysiodesis)
MODERATELY EFFECTIVEPain management (analgesics)
SUPPORTIVEAnticoagulation (e.g., heparin, warfarin, DOACs)
MODERATELY EFFECTIVEPhysical therapy
SUPPORTIVECustom orthotics and prosthetics
SUPPORTIVESirolimus (Rapamycin)
EXPERIMENTAL Approved 2009Diagnosis
- Clinical examination
- Medical history
- Doppler ultrasound
- Magnetic resonance imaging (MRI)
- Computed tomography angiography (CTA)
- Venography
- Lymphoscintigraphy
- Genetic testing (limited utility, primarily for exclusion of other conditions)
History
Klippel-Trenaunay Syndrome was first described in 1900 by French physicians Maurice Klippel and Paul Trénaunay.
Recent Breakthroughs
Sirolimus Shows Promise in Reducing Symptoms of Vascular Malformations
A study published in the *Journal of Vascular Anomalies* demonstrated that sirolimus (rapamycin) can significantly reduce the size and symptoms of vascular malformations in patients with KTS.
Genetic Mosaicism Investigated in Klippel-Trenaunay Syndrome
Research is ongoing to identify the specific genetic mutations responsible for KTS, with a focus on mosaic mutations that occur during embryonic development. This may lead to more targeted therapies in the future.